Clinical trials

  • CLOZAPINE for Schizophrenia
  • Metformin for Local recurrence of prostate cancer (previously irradiated prostate bed)
  • LIDOCAINE HYDROCHLORIDE MONOHYDRATE for Major gastrointestinal or abdominal surgery | Postoperative pain (acute)
  • mitazalimab for Metastatic pancreatic ductal adenocarcinoma
  • NIPOCALIMAB for Hemolytic disease of the fetus and newborn (HDFN)
  • Dexamethasone for Traumatic brain injury (post-traumatic brain contusion with edema)
  • GAD20-209-FSP-A4, GAD20-209-FSP-A2, GAD20-209-FSP-A3, GAD20-209-FSP-A1 for Colorectal cancer (MSI‑H/dMMR) | Metastatic colorectal cancer
  • SUB190378 (RO7010939 / fenebrutinib) for Relapsing multiple sclerosis
  • Levofloxacin for Acute uncomplicated appendicitis
  • acoramidis hydrochloride for Transthyretin amyloidosis | Transthyretin amyloid cardiomyopathy (ATTR-CM)
  • TOCILIZUMAB for Relapsed/Refractory B-cell Non-Hodgkin lymphoma
  • OBINUTUZUMAB for Minimal change disease | Nephrotic syndrome